Back

Improved HLM score: prognostic impact of adding NT-proBNP in HFpEF

9 May 2026 (10:30 - 11:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - heart failure with HFpEF (1) Heart Failure with Preserved Ejection Fraction (HFpEF) Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jose Andres Cedeno Valdiviezo

Ministry of Public Health of Ecuador, Guayaquil (Ecuador)

7 More presentations in this session

Presentation thumbnail
Intrarenal hemodynamics as prognostic markers in heart failure with preserved ejection fraction
Associate Professor I. Cabac-Pogorevici (Chisinau, MD) Doctor I. Jitari (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Intrarenal hemodynamics as a mirror of systemic vascular damage in HFpEF
Doctor V. Avram (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Serum proteomic signatures of atrial fibrillation in HFpEF/HFmrEF
Doctor J. Vogel (Essen, DE)
Abstract Slides
Presentation thumbnail
Tirzepatide use in patients with heart failure with preserved ejection fraction and obesity in clinical practice
Doctor A. Villarreal Rizzo (Rochester, US)
Abstract Slides
Presentation thumbnail
Prognostic impact of left atrial strain, GLS LV and atrial mitral regurgitation in patients with HFpEF and atrial fibrillation
Mr S. Adam (Ndjamena, TD)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - heart failure with HFpEF (1)

The Event

Event poster

Heart Failure 2026

9 May 2026 10:30 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources